Arlington, MA, United States of America

Cuixiang Sun

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 6.5

ph-index = 5

Forward Citations = 41(Granted Patents)


Location History:

  • Watertown, MA (US) (2016 - 2018)
  • Arlington, MA (US) (2013 - 2021)

Company Filing History:


Years Active: 2013-2021

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: Pioneering Inventor: Cuixiang Sun's Journey of Innovation

Introduction:

Cuixiang Sun, a distinguished inventor based in Arlington, MA (US), is a trailblazer in the realm of technology. With a remarkable track record of 7 patents to his name, Sun's work has left a lasting impact on the field of pharmaceuticals.

Latest Patents:

Among his latest patents is the groundbreaking invention of Tetracycline compounds. This innovation is directed towards a compound represented by Structural Formula (I) and its therapeutic applications. Sun's contributions to the development of pharmaceutical compositions have opened new avenues in the medical industry.

Career Highlights:

Having worked at prestigious institutions such as Tetraphase Pharmaceuticals, Inc. and Harvard University, Cuixiang Sun has honed his skills and expertise in the field of pharmaceutical research. His dedication to innovation and technical acumen have propelled him to the forefront of cutting-edge discoveries.

Collaborations:

Throughout his career, Cuixiang Sun has collaborated with esteemed professionals such as Xiao-Yi Xiao and Roger B Clark. These partnerships have fostered creativity and ingenuity, leading to collaborative breakthroughs in the realm of pharmaceutical science.

Conclusion:

In conclusion, Cuixiang Sun's unwavering passion for innovation, combined with his technical prowess, has established him as a visionary in the world of technology. His contributions continue to inspire aspiring inventors and innovators, shaping the landscape of pharmaceutical research for generations to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…